Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Konopkina, B. Basina (Dnipropetrovsk, Ukraine). Main and additional predictors of COPD progression. Eur Respir J 2014; 44: Suppl. 58, 3974

Member's Comments

No comment yet.

Related content which might interest you: Cardiovascular comorbidity in COPD: Tip of iceberg Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Factors influencing cognitive function in COPD Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Pharmacological treatment of COPD in the on-sint cohort Source: International Congress 2014 – COPD exacerbations Year: 2014 Influence of psychological characteristics of patients for asthma control Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Relation of plasma osteopontin levels with the clinical course in patients with COPD Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Investigation of the Clinical, Radiological and Biological Factors Associated with Disease Progression, Phenotypes and Endotypes of COPD in China (COMPASS): study design, protocol and rationale Source: ERJ Open Res, 7 (3) 00201-2021; 10.1183/23120541.00201-2021 Year: 2021 The German COPD cohort COSYCONET: Aims, methods and results of recruitment Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Cross-sectional analysis of the Belgian severe asthma registry (BSAR) Source: International Congress 2014 – Direct and indirect monitoring of comorbidities Year: 2014 Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control Source: International Congress 2014 – Airway biomarkers Year: 2014 Importance of concomitant local and systemic eosinophilia in uncontrolled asthma Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Sputum YKL-40 is a potential biomarker of COPD-asthma overlap Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Urinary LTE4 may be associated with TH2-driven asthma: Initial data from the Pan-European U-BIOPRED IMI project Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Update on CADSET (Chronic Airway Disease Early Stratification) Clinical Research Collaboration Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020 Asthma control is not related to large airways function Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Biomarkers for sputum eosinophilia in mild-moderate and severe adult-onset asthma patients Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Associated factors with persistent airflow limitation in asthma in U-BIOPRED Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Laboratory and clinical parameters in predicting risk of future exacerbations in both non-smoking and smoking COPD patients Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Assessment of patients preferences regarding characteristics associated with treatment of chronic obstructive pulmonary disease Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Comparison of Eosinophilic and Non-eosinophilic Cases with Chronic Obstructive Pulmonary Disease (COPD) in terms of Clinical Arrival, Exacerbations, Quality of Life and Response to Treatment: A Prospective Study Source: International Congress 2019 – Airway diseases and blood cells Year: 2019